Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05208671 · ClinicalTrials.gov registry record · NA
Nutrition to Optimize, Understand, and Restore Insulin Sensitivity in HIV for Oklahoma
A NA study of HIV and Insulin Resistance, sponsored by University of Oklahoma.
- Recruiting
- Registry status
- NA
- Development phase
- 234
- Enrollment target
- 1
- Study location
NCT05208671: Recruiting NA study of HIV and Insulin Resistance, sponsored by University of Oklahoma.
NCT05208671 is a NA study of HIV and Insulin Resistance that is actively recruiting participants, run by University of Oklahoma. The registered enrollment target is 234 participants, below the 439-participant average among 303 other HIV trials with a reported enrollment target (47% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05208671, a NA study of HIV and Insulin Resistance, is actively recruiting participants, sponsored by University of Oklahoma.
- RECRUITING
- Registry status
- NA
- Development phase
- 234 participants
- Enrollment target
- 1
- Study location
Study Summary
The NOURISH-OK Study will identify how food insecurity contributes to insulin resistance, an important surrogate marker of many co-morbidities in HIV disease, using an integrated framework to identify key leverage points for insulin resistance. Drawing from these pathways, this study will adapt and evaluate a community-driven, science-informed "food as medicine" intervention designed to lower insulin resistance through healthy food access, food utilization skills, and other self-care behaviors. Knowledge gained from this study can benefit those living with HIV through the prevention and more effective management of pre-diabetes, diabetes, obesity, and non-alcoholic fatty liver disease.
Primary Outcome
Quantitative Insulin-Sensitivity Check Index (QUICKI)
Conditions Studied
Interventions
- OTHER NOURISH Food Box
Study Locations (1)
Oklahoma
- OU Integrative Immunology Center - Tulsa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 234 participants |
| Start Date | 2020-10-09 |
| Est. Completion | 2025-12 |
| Phase | NA |
What NCT05208671 shows while recruiting
NCT05208671 is an interventional study that assigns participants to a tested intervention. The registered 234 participants enrollment target is mid-sized for trials with a published cap, below the 439-participant average among 303 other HIV trials with a reported enrollment target (47% lower).
The record links to 3 conditions, with HIV appearing as the primary indexed condition, and to 1 intervention - of which NOURISH Food Box is the first listed.
NCT05208671 reports a single indexed study location in Oklahoma.
Frequently Asked Questions
What is clinical trial NCT05208671 about?
NCT05208671 is a clinical study titled "Nutrition to Optimize, Understand, and Restore Insulin Sensitivity in HIV for Oklahoma". The NOURISH-OK Study will identify how food insecurity contributes to insulin resistance, an important surrogate marker of many co-morbidities in HIV disease, using an integrated framework to identify key leverage points for insulin resistance. Drawing from these pathways, this study will adapt and ...
What is the current status of trial NCT05208671?
This trial is currently recruiting. It is a NA study. The enrollment target is 234 participants. The study started on 2020-10-09. Estimated completion is 2025-12.
What conditions does trial NCT05208671 study?
This clinical trial studies the following conditions: HIV, Insulin Resistance, Food Insecurity.
What interventions are being tested in trial NCT05208671?
The interventions under investigation include: NOURISH Food Box (OTHER).
Who is sponsoring clinical trial NCT05208671?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05208671 being conducted?
This trial has 1 study location across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05208671's enrollment target sits among peer trials
234 91st of 303 higher than 213 of 303 other HIV trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Text Education About Cardiovascular Health and HIV (TEACH-HIV)
RECRUITING · NA
-
1MoreStep: An Intervention to Increase HIV Care Engagement and Reduce Intimate Partner Violence Among Black Women Living With HIV
RECRUITING · NA
-
Implementation Trial to Evaluate a Population Health Combination Intervention to Meet HIV Testing, Linkage, and Viral Suppression Goals in Alabama
RECRUITING · NA
-
ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services
RECRUITING · NA
-
Assessing Peer Support for Physical Activity in Women With HIV and Hypertension
RECRUITING · NA
-
Open Trial of Trauma-focused Psychodynamic Psychotherapy for People Living With HIV and PTSD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04942717 · 234 participants · NA
Adapting for Latinx Populations an Intervention That Involves Discussing and Sharing Patients' Health-Related Values
- NCT05444465 · 234 participants · NA
Use of the REGENETEN™ Bioinductive Implant System in High Grade Partial-thickness Tears
- NCT05720338 · 234 participants · Phase 3
Is Intraperitoneal Drainage Necessary Following Distal Pancreatectomy?
- NCT06047301 · 234 participants · NA
Pathways, a Hope Intervention to Support Personal Goal Pursuit, Mental Health, and Quality of Life During Advanced Lung Cancer Treatment
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI